HIV update 2002: Delaying treatment to curb rising resistance

Article Type

Article

Changed

Mon, 12/17/2018 - 09:06

Display Headline

HIV update 2002: Delaying treatment to curb rising resistance

Author(s)

Wendy Armstrong, MD

Leonard Calabrese, DO

Alan Taege, MD

Article PDF

content_69_995.pdf

Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 69(12)

Publications

Cleveland Clinic Journal of Medicine

Topics

Infectious Diseases

Immunology

Drug Therapy

Page Number

995-999

Sections

Medical Grand Rounds

Author(s)

Wendy Armstrong, MD

Leonard Calabrese, DO

Alan Taege, MD

Author(s)

Wendy Armstrong, MD

Leonard Calabrese, DO

Alan Taege, MD

Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic

Leonard Calabrese, DO
Section Head, Clinical Immunology, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Alan Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Wendy Armstrong, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: armstrw@ccf.org

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF

content_69_995.pdf

Article PDF

content_69_995.pdf

Issue

Cleveland Clinic Journal of Medicine - 69(12)

Issue

Cleveland Clinic Journal of Medicine - 69(12)

Page Number

995-999

Page Number